Markets:

Overview

News

Currencies

International

Treasuries

Minerva Neurosciences, Inc - Common Stock (NQ:NERV)

4.965 -0.135 (-2.65%)

Streaming Delayed Price Updated: 10:06 AM EDT, Jul 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Minerva Neurosciences, Inc - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 28, 2023

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.

Via Benzinga

Nasdaq Moves Higher; US Crude Stocks Drop More than Projected ↗

June 28, 2023

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 80 points on Wednesday. The Dow traded down 0.42% to 33,784.59 while the NASDAQ rose 0.63% to 13,640.83. The S&P...

Via Benzinga

Minerva Neurosciences Inc. (NASDAQ: NERV) Near the Top of Equities by Percentage Gain on 6/28

June 28, 2023

Via Investor Brand Network

Earnings Preview For Minerva Neurosciences ↗

May 12, 2023

Via Benzinga

Minerva Neurosciences Inc. (NASDAQ: NERV) Leading the Way in Monday Trading Based on Percentage Gain

May 01, 2023

Via Investor Brand Network

Earnings Preview For Minerva Neurosciences ↗

March 07, 2023

Via Benzinga

Why Minerva Neurosciences Stock Is Shooting Higher Today ↗

June 28, 2023

Minerva Neurosciences, Inc (NASDAQ: NERV) are shooting higher after the company bagged a $20 million investment from Boehringer Ingelheim and Federated Hermes Kaufmann Funds via

Via Benzinga

Snowflake, Beazer Homes, Joby Aviation And Other Big Stocks Moving Higher On Wednesday ↗

June 28, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Dow Drops 100 Points; General Mills Posts Downbeat Sales ↗

June 28, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.30% to 33,823.27 while the NASDAQ fell...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 28, 2023

Via Benzinga

Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market

June 28, 2023

From Minerva Neurosciences, Inc

Via GlobeNewswire

Minerva Neurosciences Reports 2023 First Quarter Financial Results and Business Updates

May 15, 2023

Company to host conference call today at 8:30 a.m. ET

From Minerva Neurosciences, Inc

Via GlobeNewswire

Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia

May 10, 2023

From Minerva Neurosciences, Inc

Via GlobeNewswire

Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023

May 08, 2023

Management to Host Conference Call

From Minerva Neurosciences, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 01, 2023

Via Benzinga

Minerva Neurosciences Announces the NDA Filing for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia

May 01, 2023

FDA grants appeal and files NDA

From Minerva Neurosciences, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 26, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 11, 2023

Via Benzinga

Minerva Neurosciences Reports Fiscal Year 2022 Fourth Quarter And Year End Financial Results And Business Updates

March 08, 2023

Company to Host Conference Call Today at 8:30 a.m. ET

From Minerva Neurosciences, Inc

Via GlobeNewswire

Minerva Neurosciences to Report Fiscal Year 2022 Financial Results and Business Updates on March 8, 2023

March 01, 2023

Management to Host Conference Call

From Minerva Neurosciences, Inc

Via GlobeNewswire

Earnings Scheduled For March 8, 2023 ↗

March 08, 2023

Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 11, 2023

Via Benzinga

EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch ↗

December 29, 2022

Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information....

Via Benzinga

Tesla, Amazon, Minerva, Kala Pharma, Gorilla Tech: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

December 28, 2022

Major Wall Street indices closed in the red on Wednesday as investors and traders lost optimism regarding any possible year-end rebound and braced themselves for the new year while lightening up on...

Via Benzinga

Nasdaq Down 100 Points; Kala Pharmaceuticals Shares Spike Higher ↗

December 28, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 100 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 28, 2022

Via Benzinga

Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session ↗

December 28, 2022

Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal...

Via Benzinga

Dow Tumbles 150 Points; Crude Oil Falls Sharply ↗

December 28, 2022

U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Wednesday.

Via Benzinga

US Stocks Rise; Dow Gains 100 Points ↗

December 28, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Wednesday.

Via Benzinga

Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia

December 28, 2022

From Minerva Neurosciences, Inc

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.